Crossmark

Biologics in refractory myositis: experience in juvenile vs. adult myositis; part II: emerging biologic and other therapies on the horizon

Published Online: 2019-08-20

Published Print: 2019-12

Authors

Patwardhan, Anjali https://orcid.org/0000-0002-1467-1011
Spencer, Charles H.
License Information

Text and Data Mining valid from 2019-08-20

Version of Record valid from 2019-08-20
More Information

Article History

Received: 25 June 2019

Accepted: 8 August 2019

First Online: 20 August 2019

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current